BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30636484)

  • 1. Increased Expression of MicroRNA-206 Inhibits Potassium Voltage-Gated Channel Subfamily A Member 5 in Pulmonary Arterial Smooth Muscle Cells and Is Related to Exaggerated Pulmonary Artery Hypertension Following Intrauterine Growth Retardation in Rats.
    Lv Y; Fu L; Zhang Z; Gu W; Luo X; Zhong Y; Xu S; Wang Y; Yan L; Li M; Du L
    J Am Heart Assoc; 2019 Jan; 8(2):e010456. PubMed ID: 30636484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
    Lv Y; Tang LL; Wei JK; Xu XF; Gu W; Fu LC; Zhang LY; Du LZ
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L856-65. PubMed ID: 24077947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of Kv1.5 is upregulated in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
    Fu LC; Lv Y; Zhong Y; He Q; Liu X; Du LZ
    Braz J Med Biol Res; 2017 Sep; 50(11):e6237. PubMed ID: 28902925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
    Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
    Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
    Mondejar-Parreño G; Callejo M; Barreira B; Morales-Cano D; Esquivel-Ruiz S; Moreno L; Cogolludo A; Perez-Vizcaino F
    J Physiol; 2019 Feb; 597(4):1185-1197. PubMed ID: 29717493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
    Zhai FG; Zhang XH; Wang HL
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
    Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
    Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
    Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
    Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
    Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-mediated downregulation of K
    Babicheva A; Ayon RJ; Zhao T; Ek Vitorin JF; Pohl NM; Yamamura A; Yamamura H; Quinton BA; Ba M; Wu L; Ravellette KS; Rahimi S; Balistrieri F; Harrington A; Vanderpool RR; Thistlethwaite PA; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L10-L26. PubMed ID: 31553627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.
    Kang K; Peng X; Zhang X; Wang Y; Zhang L; Gao L; Weng T; Zhang H; Ramchandran R; Raj JU; Gou D; Liu L
    J Biol Chem; 2013 Aug; 288(35):25414-25427. PubMed ID: 23853098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.
    Li Q; Qian Z; Wang L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1351-1361. PubMed ID: 28496318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
    Tian H; Fan F; Geng J; Deng J; Tian H
    J Vasc Res; 2019; 56(4):204-214. PubMed ID: 31189158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human models.
    Michelakis ED; Dyck JR; McMurtry MS; Wang S; Wu XC; Moudgil R; Hashimoto K; Puttagunta L; Archer SL
    Adv Exp Med Biol; 2001; 502():401-18. PubMed ID: 11950153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells.
    Yuan XJ; Wang J; Juhaszova M; Golovina VA; Rubin LJ
    Am J Physiol; 1998 Apr; 274(4):L621-35. PubMed ID: 9575881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
    Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: epigenetics in PAH following IUGR.
    Xu XF; Lv Y; Gu WZ; Tang LL; Wei JK; Zhang LY; Du LZ
    Respir Res; 2013 Feb; 14(1):20. PubMed ID: 23406533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.